サマリー

非侵襲的非経口的スクリーニングは、母親の血清中に存在する胎児の細胞遊離DNAを検査し、一般的な胎児の異数性を検出する新しい遺伝学的プロセスである。その主な目的は、トリソミー21（ダウン症候群）、トリソミー18（エドワード症候群）、トリソミー13（パタウ症候群）、モノソミーX（ターナー症候群）などの遺伝性疾患の早期発見です。また、胎児の血液型やアカゲザルを検出することもできます。現在、世界市場で販売されているNIPTの中には、MaterniT21 PLUS、Harmony、Panorama、NIFTY、PrenaTest、BambniTestなどの製品があります。

市場分析と洞察。非侵襲的非経口的スクリーニングの世界市場
非侵襲的非経口スクリーニングの世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに達すると予測され、2021年から2027年の間にXX％のCAGRで推移します。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の非侵襲性非経口投与スクリーニング市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界の非侵襲的非経口的スクリーニング市場の全体的なサイズも含まれています。
本レポートは、非侵襲的非経口的スクリーニングの世界市場において、競合他社に対して優位に立ち、永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の非侵襲的非経口的スクリーニング市場を詳細に調査するために、独自の、そして業界で最も優れた調査と分析のアプローチを取りました。

世界の非侵襲的非経口投与スクリーニングの範囲と市場規模
非侵襲的非経口的スクリーニング市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されます。世界の非侵襲的非経口的スクリーニング市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
機器類
消耗品

アプリケーション別セグメント
診断機関
病院

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
GEヘルスケア
フィリップス
イルミナ
サーモフィッシャーサイエンティフィック
ロシュ
パックバイオ
パーキネルマー
チーゲン
アジレント・テクノロジー
BGIグループ

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-invasive Parenteral Screening Market Perspective (2016-2027)
2.2 Non-invasive Parenteral Screening Growth Trends by Regions
2.2.1 Non-invasive Parenteral Screening Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-invasive Parenteral Screening Historic Market Share by Regions (2016-2021)
2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Regions (2022-2027)
2.3 Non-invasive Parenteral Screening Industry Dynamic
2.3.1 Non-invasive Parenteral Screening Market Trends
2.3.2 Non-invasive Parenteral Screening Market Drivers
2.3.3 Non-invasive Parenteral Screening Market Challenges
2.3.4 Non-invasive Parenteral Screening Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Parenteral Screening Players by Revenue
3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2016-2021)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2016-2021)
3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio
3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2020
3.5 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.6 Key Players Non-invasive Parenteral Screening Product Solution and Service
3.7 Date of Enter into Non-invasive Parenteral Screening Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Parenteral Screening Breakdown Data by Type
4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2016-2021)
4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2022-2027)

5 Non-invasive Parenteral Screening Breakdown Data by Application
5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2016-2021)
5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-invasive Parenteral Screening Market Size (2016-2027)
6.2 North America Non-invasive Parenteral Screening Market Size by Type
6.2.1 North America Non-invasive Parenteral Screening Market Size by Type (2016-2021)
6.2.2 North America Non-invasive Parenteral Screening Market Size by Type (2022-2027)
6.2.3 North America Non-invasive Parenteral Screening Market Size by Type (2016-2027)
6.3 North America Non-invasive Parenteral Screening Market Size by Application
6.3.1 North America Non-invasive Parenteral Screening Market Size by Application (2016-2021)
6.3.2 North America Non-invasive Parenteral Screening Market Size by Application (2022-2027)
6.3.3 North America Non-invasive Parenteral Screening Market Size by Application (2016-2027)
6.4 North America Non-invasive Parenteral Screening Market Size by Country
6.4.1 North America Non-invasive Parenteral Screening Market Size by Country (2016-2021)
6.4.2 North America Non-invasive Parenteral Screening Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-invasive Parenteral Screening Market Size (2016-2027)
7.2 Europe Non-invasive Parenteral Screening Market Size by Type
7.2.1 Europe Non-invasive Parenteral Screening Market Size by Type (2016-2021)
7.2.2 Europe Non-invasive Parenteral Screening Market Size by Type (2022-2027)
7.2.3 Europe Non-invasive Parenteral Screening Market Size by Type (2016-2027)
7.3 Europe Non-invasive Parenteral Screening Market Size by Application
7.3.1 Europe Non-invasive Parenteral Screening Market Size by Application (2016-2021)
7.3.2 Europe Non-invasive Parenteral Screening Market Size by Application (2022-2027)
7.3.3 Europe Non-invasive Parenteral Screening Market Size by Application (2016-2027)
7.4 Europe Non-invasive Parenteral Screening Market Size by Country
7.4.1 Europe Non-invasive Parenteral Screening Market Size by Country (2016-2021)
7.4.2 Europe Non-invasive Parenteral Screening Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Parenteral Screening Market Size (2016-2027)
8.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type
8.2.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application
8.3.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region
8.4.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-invasive Parenteral Screening Market Size (2016-2027)
9.2 Latin America Non-invasive Parenteral Screening Market Size by Type
9.2.1 Latin America Non-invasive Parenteral Screening Market Size by Type (2016-2021)
9.2.2 Latin America Non-invasive Parenteral Screening Market Size by Type (2022-2027)
9.2.3 Latin America Non-invasive Parenteral Screening Market Size by Type (2016-2027)
9.3 Latin America Non-invasive Parenteral Screening Market Size by Application
9.3.1 Latin America Non-invasive Parenteral Screening Market Size by Application (2016-2021)
9.3.2 Latin America Non-invasive Parenteral Screening Market Size by Application (2022-2027)
9.3.3 Latin America Non-invasive Parenteral Screening Market Size by Application (2016-2027)
9.4 Latin America Non-invasive Parenteral Screening Market Size by Country
9.4.1 Latin America Non-invasive Parenteral Screening Market Size by Country (2016-2021)
9.4.2 Latin America Non-invasive Parenteral Screening Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Parenteral Screening Market Size (2016-2027)
10.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type
10.2.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application
10.3.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country
10.4.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Philips
11.2.1 Philips Company Details
11.2.2 Philips Business Overview
11.2.3 Philips Non-invasive Parenteral Screening Introduction
11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.2.5 Philips Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Non-invasive Parenteral Screening Introduction
11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Non-invasive Parenteral Screening Introduction
11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.5.5 Roche Recent Development
11.6 PacBio
11.6.1 PacBio Company Details
11.6.2 PacBio Business Overview
11.6.3 PacBio Non-invasive Parenteral Screening Introduction
11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.6.5 PacBio Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Details
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.7.5 Perkinelmer Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Non-invasive Parenteral Screening Introduction
11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.8.5 Qiagen Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.9.5 Agilent Technologies Recent Development
11.10 BGI Group
11.10.1 BGI Group Company Details
11.10.2 BGI Group Business Overview
11.10.3 BGI Group Non-invasive Parenteral Screening Introduction
11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.10.5 BGI Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details